Clinical Trials Browser

Phase 2 × Neoplasms, Germ Cell and Embryonal × Nivolumab × Clear all

NCT03726281 2019-08-21

Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors

Phase 2 Withdrawn

Neoplasms, Germ Cell and Embryonal